Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Long-term study of K-877 add-on to HMG-CoA reductase inhibitor in dyslipidemia
jRCT2080222021Phase 3
- Sponsor
- Kowa Company, Ltd.
- Start
- Feb 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in dyslipidemia and hypertriglyceridemia comparing K-877 add-on arm with Placebo add-on arm (2 arms).
02
Drugs
pemafibrate
03
Conditions
dyslipidemiahypertriglyceridemia
Beyond the preview
Go deeper on jRCT2080222021.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT2080222021.